324 related articles for article (PubMed ID: 22473726)
1. Factor V Leiden: how great is the risk of venous thromboembolism?
Shaheen K; Alraies MC; Alraiyes AH; Christie R
Cleve Clin J Med; 2012 Apr; 79(4):265-72. PubMed ID: 22473726
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation.
Tzoran I; Papadakis M; Brenner B; Fidalgo Á; Rivas A; Wells PS; Gavín O; Adarraga MD; Moustafa F; Monreal M;
Am J Med; 2017 Apr; 130(4):482.e1-482.e9. PubMed ID: 27986523
[TBL] [Abstract][Full Text] [Related]
3. Do incident and recurrent venous thromboembolism risks truly differ between heterozygous and homozygous Factor V Leiden carriers? A retrospective cohort study.
Perez Botero J; Ormsby WD; Ashrani AA; McBane RD; Wysokinski WE; Patnaik MM; Lewis BR; Grill DE; Pruthi RK; Heit JA
Eur J Intern Med; 2016 May; 30():77-81. PubMed ID: 26970916
[TBL] [Abstract][Full Text] [Related]
4. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
Emmerich J; Rosendaal FR; Cattaneo M; Margaglione M; De Stefano V; Cumming T; Arruda V; Hillarp A; Reny JL
Thromb Haemost; 2001 Sep; 86(3):809-16. PubMed ID: 11583312
[TBL] [Abstract][Full Text] [Related]
5. Classic thrombophilic gene variants.
Mannucci PM; Franchini M
Thromb Haemost; 2015 Nov; 114(5):885-9. PubMed ID: 26018405
[TBL] [Abstract][Full Text] [Related]
6. Thrombin generation in first-degree relatives of patients with venous thromboembolism who have factor V Leiden. A pilot study.
Couturaud F; Duchemin J; Leroyer C; Delahousse B; Abgrall JF; Mottier D;
Thromb Haemost; 2008 Jan; 99(1):223-8. PubMed ID: 18217158
[TBL] [Abstract][Full Text] [Related]
7. Type and location of venous thromboembolism in carriers of Factor V Leiden or prothrombin G20210A mutation versus patients with no mutation.
Kovac M; Mitic G; Mikovic Z; Antonijevic N; Djordjevic V; Mikovic D; Mandic V; Rakicevic L; Radojkovic D
Clin Appl Thromb Hemost; 2010 Feb; 16(1):66-70. PubMed ID: 18796457
[TBL] [Abstract][Full Text] [Related]
8. Do heterozygous factor V Leiden and prothrombin G20210A mutations have different impact on the type and location of venous thromboembolism?
Chevalier Y; Mandrillon G; Bestion A; Lega JC; Piquet P; Ninet J; Dargaud Y
Int Angiol; 2014 Aug; 33(4):404-5. PubMed ID: 25056173
[No Abstract] [Full Text] [Related]
9. The thrombophilic pattern of different clinical manifestations of venous thromboembolism: a survey of 443 cases of venous thromboembolism.
Grifoni E; Marcucci R; Ciuti G; Cenci C; Poli D; Mannini L; Liotta AA; Miniati M; Abbate R; Prisco D
Semin Thromb Hemost; 2012 Mar; 38(2):230-4. PubMed ID: 22422337
[TBL] [Abstract][Full Text] [Related]
10. Factor V Leiden: a case study and review.
Slusher KB
Dimens Crit Care Nurs; 2010; 29(1):6-10. PubMed ID: 20010186
[TBL] [Abstract][Full Text] [Related]
11. FV Leiden mutation and risk of recurrent venous thromboembolism in Serbian population.
Kovac M; Mikovic D; Antonijevic N; Rakicevic L; Djordjevic V; Radojkovic D; Elezovic I
J Thromb Thrombolysis; 2008 Jun; 25(3):284-7. PubMed ID: 17549437
[TBL] [Abstract][Full Text] [Related]
12. Inherited thrombophilia and first venous thromboembolism during pregnancy and puerperium.
Martinelli I; De Stefano V; Taioli E; Paciaroni K; Rossi E; Mannucci PM
Thromb Haemost; 2002 May; 87(5):791-5. PubMed ID: 12038778
[TBL] [Abstract][Full Text] [Related]
13. Optimal duration of anticoagulation. Provoked versus unprovoked VTE and role of adjunctive thrombophilia and imaging tests.
Prandoni P; Barbar S; Milan M; Campello E; Spiezia L; Piovella C; Pesavento R
Thromb Haemost; 2015 Jun; 113(6):1210-5. PubMed ID: 25119194
[TBL] [Abstract][Full Text] [Related]
14. Gender-related differences in the outcome of patients with venous thromboembolism and thrombophilia.
Tzoran I; Papadakis E; Brenner B; Valle R; López-Jiménez L; García-Bragado F; Riera-Mestre A; Villalobos A; Quintavalla R; Monreal M;
Thromb Res; 2017 Mar; 151 Suppl 1():S11-S15. PubMed ID: 28262227
[TBL] [Abstract][Full Text] [Related]
15. Impact of inherited thrombophilia on the risk of recurrent venous thromboembolism onset in Georgian population.
Pirtskhelani N; Kochiashvili N; Makhaldiani L; Pargalava N; Gaprindashvili E; Kartvelishvili K
Georgian Med News; 2014 Feb; (227):93-7. PubMed ID: 24632656
[TBL] [Abstract][Full Text] [Related]
16. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
[TBL] [Abstract][Full Text] [Related]
17. Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia.
Martinelli I; Legnani C; Bucciarelli P; Grandone E; De Stefano V; Mannucci PM
Thromb Haemost; 2001 Sep; 86(3):800-3. PubMed ID: 11583310
[TBL] [Abstract][Full Text] [Related]
18. [Incidence of thrombophilia and risk of renal vessel thrombosis in kidney transplant recipients].
Toronyi E; Máthé Z; Chmel R; Varga M; Kozma V; Trent R; Tozsér G; Nagy G; Langer R
Magy Seb; 2011 Oct; 64(5):229-34. PubMed ID: 21997526
[TBL] [Abstract][Full Text] [Related]
19. A 40-Year-Old Man with Sarcoidosis and Factor V Leiden Thrombophilia Presenting with Deep Vein Thrombosis and Pulmonary Thromboembolism.
Goljan-Geremek A; Puścińska E; Tomkowski W; Śliwiński P
Am J Case Rep; 2021 Jul; 22():e932286. PubMed ID: 34326300
[TBL] [Abstract][Full Text] [Related]
20. Activated protein C resistance, factor V Leiden and assessment of thrombotic risk.
Gilmore R; Doyle M; Holden F; White B; O'Donnell J
Ir Med J; 2008 Sep; 101(8):256-7. PubMed ID: 18990960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
